These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2511097)

  • 21. Oral idarubicin in combination with cytosine-arabinoside in previously untreated patients with acute non-lymphocytic leukemia.
    Falkson G; Coccia-Portugal MA; Vorobiof DA; Terblanche AP; Dreyer R
    Am J Clin Oncol; 1986 Aug; 9(4):311-4. PubMed ID: 3463190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined chemotherapy with m-amsacrine in high-risk patients with acute non-lymphocytic leukemia.
    Maschmeyer G; Hiddemann W; Kreutzmann H; Wendt F
    Onkologie; 1987 Feb; 10(1):18-21. PubMed ID: 3295621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complete remission without marrow aplasia phase in a patient with acute promyelocytic leukosis treated with aggressive chemotherapy].
    del Potro Gómez E; Martínez Martínez R; López Martín JC; Díaz Morfa M; Díaz Mediavilla J; Espinos Pérez D
    An Med Interna; 1989 May; 6(5):255-6. PubMed ID: 2491539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HATP chemotherapy combined with Chinese traditional medications in treating acute promyelocytic leukemia].
    Guo AX; Huang SL; Wang QE
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):470-2. PubMed ID: 8275827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemia.
    Dekker AW; Nieuwenhuis HK; Verdonck LF
    Cancer; 1990 May; 65(9):1891-4. PubMed ID: 2372760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of alternating as well as long-term intensive polychemotherapy in the remission-maintaining treatment of patients with acute myelocytic leukemia].
    Hansz J; Bajko G; Woźny T; Drozdowska D
    Pol Arch Med Wewn; 1992 Feb; 87(2):127-33. PubMed ID: 1523139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for relapsed and resistant acute nonlymphoblastic leukemia. Effect of ATA, an amsacrine-containing regime.
    Liang R; Chan TK; Todd D
    Cancer Chemother Pharmacol; 1988; 21(1):68-70. PubMed ID: 3342467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital.
    Cunningham I; Gee TS; Reich LM; Kempin SJ; Naval AN; Clarkson BD
    Blood; 1989 Apr; 73(5):1116-22. PubMed ID: 2930837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reinduction chemotherapy for acute nonlymphocytic leukemia.
    Letendre L; Kiely JM; Hoagland HC
    Mayo Clin Proc; 1984 Sep; 59(9):618-21. PubMed ID: 6381915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute promyelocytic leukemia with T-cell markers and particular response to treatment. Report of a case.
    Berceanu S; Roman S; Moldoveanu E; Ursea C; Munteanu N
    Haematologica; 1989; 74(1):75-9. PubMed ID: 2498188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia.
    Thomas X; Fiere D; Archimbaud E
    Leukemia; 1998 Sep; 12(9):1503-6. PubMed ID: 9737708
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia.
    Dekker AW; Punt K; Verdonck LF
    Haematol Blood Transfus; 1987; 30():333-5. PubMed ID: 3623240
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytosine arabinoside in experimental combination therapy.
    Edelstein M; Valeriote F
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):75-83. PubMed ID: 3892705
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.
    Skeel RT; Costello W; Bennett JM; Oken MM; Tobin MS; Bertino JR; Marsh JC; Carbone PP
    Cancer; 1980 Jan; 45(2):224-31. PubMed ID: 6985830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose cytosine arabinoside with amsacrine for treatment of acute lymphoblastic leukemia.
    Arlin ZA
    J Clin Oncol; 1986 Dec; 4(12):1868. PubMed ID: 3465878
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia.
    Preisler HD; Azarnia N; Raza A; Grunwald H; Vogler R; Browman G; Goldberg J; Chervenick P; Miller K; Brennan J
    Br J Haematol; 1984 Mar; 56(3):399-407. PubMed ID: 6582925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy.
    Arlin Z; Kempin S; Mertelsmann R; Gee T; Higgins C; Jhanwar S; Chaganti RS; Clarkson B
    Blood; 1984 Jan; 63(1):211-2. PubMed ID: 6580926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.